当前位置:首页 - 行情中心 - 益盛药业(002566) - 财务分析 - 资产负债表

益盛药业

(002566)

  

流通市值:15.23亿  总市值:21.74亿
流通股本:2.32亿   总股本:3.31亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金446,022,778.54426,920,881.92435,152,569.03343,263,877.76
应收票据及应收账款186,885,606.39175,170,234.9203,285,515.07191,229,729.08
其中:应收票据1,402,899.821,646,178.011,665,456.751,544,397.91
应收账款185,482,706.57173,524,056.89201,620,058.32189,685,331.17
应收款项融资40,929,904.9757,489,663.5238,652,745.9872,772,571.28
预付款项6,350,916.458,026,868.435,629,857.675,276,818.91
应收保费4,223,230.59--20,571,527.06
其他应收款合计-7,959,741.3520,496,650.9620,571,527.06
存货1,613,630,489.161,594,013,077.681,592,167,434.21,603,100,929.5
其他流动资产1,761,751.811,857,954.82,824,400.696,554,019.94
流动资产平衡项目0000
流动资产合计2,400,754,341.422,371,324,153.632,359,212,920.222,302,612,638.12
非流动资产:
固定资产484,841,675.35493,169,849.23500,874,651.08509,049,720.37
在建工程400,000400,000400,0001,977,269.79
使用权资产12,615,892.2612,993,685.714,038,106.7315,082,527.52
无形资产114,895,018.2115,603,760.31116,365,232.92117,025,079.32
商誉1,905,827.331,905,827.331,905,827.331,905,827.33
长期待摊费用2,374,112.442,584,864.782,802,400.963,072,931.61
递延所得税资产13,953,543.8413,848,648.8614,723,889.9814,201,606.89
其他非流动资产1,270,610975,5602,558,564.661,679,075
非流动资产平衡项目0000
非流动资产合计632,256,679.42641,482,196.21653,668,673.66663,994,037.83
资产平衡项目0000
资产总计3,033,011,020.843,012,806,349.843,012,881,593.882,966,606,675.95
流动负债:
短期借款470,393,333.32470,393,333.34470,447,708.34430,427,013.89
应付票据及应付账款24,816,611.8221,985,039.2619,585,032.4124,326,124.97
应付账款24,816,611.8221,985,039.2619,585,032.4124,326,124.97
合同负债15,954,59613,534,213.823,044,819.7724,509,324.03
应付职工薪酬6,959,935.137,909,207.579,987,315.0610,020,225.7
应交税费11,484,997.0216,282,821.3421,705,430.3318,820,804.32
其他应付款合计77,897,484.3169,222,783.6252,278,965.4773,752,881.42
应付股利-16,547,580--
一年内到期的非流动负债3,134,811.13,121,971.552,983,977.553,294,463.52
其他流动负债1,902,092.341,585,687.882,815,507.433,013,834.8
流动负债平衡项目0000
流动负债合计612,543,861.04604,035,058.36602,848,756.36588,164,672.65
非流动负债:
租赁负债7,269,562.697,692,339.597,831,519.299,824,687.77
递延收益118,894,288.52117,124,723.77120,094,276.96118,023,199.29
递延所得税负债1,223,713.091,108,608.471,287,838.741,166,060.87
非流动负债平衡项目0000
非流动负债合计127,387,564.3125,925,671.83129,213,634.99129,013,947.93
负债平衡项目0000
负债合计739,931,425.34729,960,730.19732,062,391.35717,178,620.58
所有者权益(或股东权益):
实收资本(或股本)330,951,600330,951,600330,951,600330,951,600
资本公积834,689,338.39834,689,338.39834,689,338.39834,689,338.39
盈余公积132,142,747.38132,142,747.38132,142,747.38132,142,747.38
未分配利润899,116,465.58888,075,242.89885,897,062.18857,194,500.03
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计2,196,900,151.352,185,858,928.662,183,680,747.952,154,978,185.8
少数股东权益96,179,444.1596,986,690.9997,138,454.5894,449,869.57
股东权益平衡项目0000
股东权益合计2,293,079,595.52,282,845,619.652,280,819,202.532,249,428,055.37
负债和股东权益合计3,033,011,020.843,012,806,349.843,012,881,593.882,966,606,675.95
公告日期2023-10-272023-08-252023-04-282023-04-19
审计意见(境内)标准无保留意见
TOP↑